Shilpa Medicare (SHILPAMED) Share Price Falls 5.95% to Rs 881.7; Sector Valuation in Focus
- September 30, 2026
- Posted by: Kunal Singla
- Category: News
Shilpa Medicare Share Price fell to Rs 881.7 in today’s trade, down 5.95% from the previous close, while the company’s market capitalisation stood at Rs 18,335.8 crore. The move places Shilpa Medicare Share Price in the middle of today’s market discussion for healthcare stocks, with investors looking at the stock’s valuation, profitability ratios and the wider pharmaceuticals comparison set. According to latest Univest data, the price event is confirmed, but no company-specific catalyst is established. As of 19 October 2026 at 10:52:58 AM IST, the stock remained active within a tight intraday band and the fall was enough to bring Shilpa Medicare Share Price, Shilpa Medicare Share Price Today and Shilpa Medicare Stock News into focus for readers tracking India’s healthcare names.
The latest Univest figures show that Shilpa Medicare Share Price is trading below its previous close, and the day’s range places the stock below the open and near the lower end of the session band. That matters for investors who follow Shilpa Medicare Share Price Today because the move is not only about a percentage drop; it also reflects a meaningful reset in the share price level compared with the start of trade. In this article, Univest reviews Shilpa Medicare Share Price, Shilpa Medicare Stock News and the key fundamentals that sit behind the stock’s current market position.
Shilpa Medicare (SHILPAMED) Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 881.7 |
| Previous Close | Rs 937.5 |
| Today's Move | -Rs 55.80 (-5.95%) |
| Open | Rs 882.4 |
| High | Rs 920.5 |
| Low | Rs 857.45 |
| Market Capitalisation | Rs 18,335.8 crore |
| Market Cap Category | Mid Cap |
Shilpa Medicare Share Price Today shows a clear intraday decline. The stock opened at Rs 882.4, touched a high of Rs 920.5 and a low of Rs 857.45, before last trading at Rs 881.7. The previous close was Rs 937.5, so the stock is down Rs 55.8, or 5.95%, in the latest session. Market capitalisation is Rs 18,335.8 crore, and the company fits the Mid Cap category for size context. For readers following Shilpa Medicare Share Price Live, the day’s range shows that the stock has moved well below its earlier level and remains a notable part of the healthcare price action conversation. Shilpa Medicare Share Price, Shilpa Medicare Share Price Today and Shilpa Medicare Share Price Update all point to the same conclusion: the stock has seen a material single-day fall, and that makes the next layer of analysis more important.
From a market-news angle, Shilpa Medicare Share Price Today is relevant because the decline came without a verified company-specific explanation in the price record. That leaves investors with the numbers first and any interpretation second. Shilpa Medicare Share Price, Shilpa Medicare Stock News and Shilpa Medicare Share Price Fall are therefore best read together with valuation and sector context rather than as a standalone price move. The immediate question shifts from what moved the stock to how its valuation and financial profile compare with listed peers and the broader healthcare set.
Shilpa Medicare (SHILPAMED) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 18,335.8 crore |
| P/E Ratio | 61.67x |
| P/B Ratio | 6.83x |
| ROE | 9.82% |
| ROCE | 11.43% |
| EPS | Rs 15.2 |
| Book Value Per Share | Rs 137.34 |
| Dividend Yield | 0.06% |
Shilpa Medicare (SHILPAMED) fundamental metrics show P/E 61.67x, P/B 6.83x, ROE 9.82%, ROCE 11.43%. These figures provide context only and are not a buy or sell signal.
Shilpa Medicare has a market capitalisation of Rs 18,335.80 crore and falls in the Mid Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 61.67x, P/B at 6.83x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 9.82% and ROCE of 11.43%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 15.2, book value per share of Rs 137.34, dividend yield of 0.06%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 30.95x, median ROE of 10.96%, median ROCE of 13.01%. Taken together, they outline the fundamentals rather than a view on the stock.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 61.67x |
| Benchmark Median P/E | 30.95x |
| Benchmark Average P/E | 46.82x |
| Benchmark P/E Range | 3.1x to 629.67x |
| Company P/B Ratio | 6.83x |
| Benchmark Median P/B | 2.82x |
| Benchmark Average P/B | 4.18x |
| Company ROE | 9.82% |
| Benchmark Median ROE | 10.96% |
| Benchmark Average ROE | 9.51% |
| Company ROCE | 11.43% |
| Benchmark Median ROCE | 13.01% |
| Benchmark Average ROCE | 12.48% |
| Company Market Capitalisation | Rs 18,335.8 crore |
| Benchmark Median Market Cap | Rs 720.23 crore |
| Benchmark Average Market Cap | Rs 13,282.41 crore |
Shilpa Medicare (SHILPAMED) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.
Shilpa Medicare (SHILPAMED) has a P/E ratio of 61.67x, which is above the benchmark median of 30.95x, a difference of +99.26%. On its own, the P/E gap is a valuation reference point, not a trading call.
Shilpa Medicare (SHILPAMED) has a ROE of 9.82%, which is below the benchmark median of 10.96%, a difference of -10.4%. Shilpa Medicare (SHILPAMED) has a ROCE of 11.43%, which is below the benchmark median of 13.01%, a difference of -12.14%.
Track stocks among today's decliners through the Univest top decliners screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | SUNPHARMA | 4,22,282.95 | 34.91 | 4.88 | 14.85 | 19.11 |
| Divi's Laboratories | DIVISLAB | 2,44,762.03 | 83.68 | 13.86 | 16.19 | 21.51 |
| Torrent Pharmaceuticals | TORNTPHARM | 1,73,447.74 | 79.53 | 19.32 | 26.76 | 19.27 |
| Zydus Lifesciences | ZYDUSLIFE | 1,12,149.36 | 24.85 | 4.16 | 19.69 | 21.39 |
| Laurus Labs | LAURUSLABS | 1,11,250.29 | 101.75 | 19.73 | 18.31 | 18.2 |
Shilpa Medicare (SHILPAMED) has a P/E ratio of 61.67x compared with the displayed peer median of 79.53x. This peer read is a relative benchmark rather than a trading signal. Its ROE of 9.82% compares with a peer median of 18.31% across the companies shown in the table. ROCE stood at 11.43% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Shilpa Medicare (SHILPAMED) has a market capitalisation of Rs 18,335.8 crore. All 5 peers shown have a larger market capitalisation.
Why Investors Are Watching Shilpa Medicare
- Shilpa Medicare Share Price fell 5.95% to Rs 881.7, which makes the stock a clear price-action watchlist name today.
- The company’s market capitalisation of Rs 18,335.8 crore places it above the benchmark median in its industry set.
- Shilpa Medicare Share Price trades at a P/E of 61.67 and a P/B of 6.83, both above the industry median.
- ROE at 9.82% and ROCE at 11.43% give investors a compact view of current profitability returns.
- Shilpa Medicare Share Price Today stands out because the stock’s valuation profile differs from several listed healthcare peers.
About Shilpa Medicare
Shilpa Medicare operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The company is positioned in a benchmark universe that includes 204 same-industry listed companies, which helps frame Shilpa Medicare Share Price in a broader market context. Its current market capitalisation and profitability ratios show it as a sizeable healthcare name rather than a niche micro entity, while its valuation multiples indicate that the market assigns it a richer price relative to earnings and book value. For readers following Shilpa Medicare Share Price, the company sits within a segment where peer comparison and industry benchmarking matter more than broad market headlines.
Track Shilpa Medicare Share Price on Univest
Use Shilpa Medicare (SHILPAMED) live share-price page, Univest top decliners screener, Univest market blogs to review live stock data, top decliners and related market analysis.
Univest lets readers track Shilpa Medicare Share Price, Shilpa Medicare Share Price Today and Shilpa Medicare Stock News in one place. You can follow live price updates, fundamental ratios, 52-week levels and market insights while keeping an eye on company-specific movement and sector context. For investors who want a cleaner view of Shilpa Medicare Share Price Update, Univest brings the price, valuation and peer lens together.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).
Frequently Asked Questions
Why is Shilpa Medicare Share Price falling today?
Ans. Shilpa Medicare Share Price fell 5.95% to Rs 881.7 from a previous close of Rs 937.5. According to Univest data, the price event is confirmed, but no company-specific catalyst is established.
What is Shilpa Medicare Share Price Today?
Ans. Shilpa Medicare Share Price Today last traded at Rs 881.7. The stock opened at Rs 882.4, touched Rs 920.5 and Rs 857.45 during the day, and remained below the previous close.
What is the market capitalisation of Shilpa Medicare?
Ans. Shilpa Medicare Share Price is backed by a market capitalisation of Rs 18,335.8 crore. In the same-industry benchmark, that is above the median market cap of Rs 720.23 crore and above the average.
How does Shilpa Medicare compare on valuation?
Ans. Shilpa Medicare Share Price trades at a P/E of 61.67 and a P/B of 6.83. Both are above the industry benchmark median, which places the stock above the sector middle on valuation multiples.
What do ROE and ROCE show for Shilpa Medicare?
Ans. Shilpa Medicare Share Price comes with ROE of 9.82% and ROCE of 11.43%. ROE is close to the industry average, while ROCE is below the benchmark median and average in the same industry.
What is the EPS and book value for Shilpa Medicare?
Ans. Shilpa Medicare Share Price has EPS of Rs 15.2 and book value of Rs 137.34 per share. EPS reflects earnings attributable to each share, while book value shows accounting net worth behind each share.
Does Shilpa Medicare pay a dividend?
Ans. Shilpa Medicare Share Price is paired with a dividend yield of 0.06%. That indicates a very small historical payout relative to the current price, so valuation and earnings remain the bigger focus.
How does Shilpa Medicare compare with listed healthcare peers?
Ans. Shilpa Medicare Share Price is smaller than major peers such as Sun Pharma, Divi’s Laboratories, Torrent Pharmaceuticals and Zydus Lifesciences on market capitalisation. Its P/E is higher than several peers, while returns are mixed.
Should investors track Shilpa Medicare Share Price on Univest?
Ans. Yes, Shilpa Medicare Share Price can be tracked on Univest for live price updates, valuation ratios, sector context and benchmark comparisons. That helps readers monitor Shilpa Medicare Share Price Today alongside peer data.
